Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Living With Dementia

dysarthria1 - mild tbi1 - sleep loss1 - hyperammonemia1 - antioxidants1 - amyloid markers1 - care or dementia1 - decline of memory1 - carotid ultrasound1 - hippocampal atrophy1 - alzheimer's drug5 - physical exercise1 - inflammation1 - reconceptualization1 - dementia care program1 - glucose hypometabolism1 - motor development1 - mild alzheimer's stage1 - repair damaged nerve tissue1 - quetiapine1 - muscle co-ordination1 - broken bones1 - thc1 - alzheimers gene1 - parkinson's dementia1 - mini-cognitive assessment1 - slowed movement1 - amyloid-targeting treatment1 - amyloid beta Αβ plaques1 - type 1 diabetes1 -